NCT04113343View on ClinicalTrials.gov

Oral Remimazolam With and Without Alcohol in Healthy Female Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

May 30, 2017

Primary Completion Date

August 9, 2017

Study Completion Date

August 9, 2017

Conditions

Safety Issues

Interventions

DRUG

Remimazolam

Remimazolam via oral administration

OTHER

Alcohol

Alcohol

Trial Locations (1)

84106

PRA Health Sciences (PRA) - Early Development Services, Salt Lake City

Sponsors

Collaborators (1)

PRA Health Sciences

All Listed Sponsors

collaborator

PRA Health Sciences

INDUSTRY

lead

Paion UK Ltd.

INDUSTRY

NCT04113343 - Oral Remimazolam With and Without Alcohol in Healthy Female Subjects | Biotech Hunter | Biotech Hunter